Grants and funders
We are grateful for the support of numerous funders who make the work of the Lochmüller Lab possible.
Hanns holds the Canada Research Chair in Neuromuscular Genomics and Health and our lab’s work is supported by funding from the Canada Research Chairs program.
We are supported by a CIHR Foundation Grant on Precision Health for Neuromuscular Diseases under grant no. FDN-167281.
The Canada Foundation for Innovation (CFI) supports equipment in our lab as part of the CRC award.
Emily O'Connor's work is supported by a stipend from the French Muscular Dystrophy Association (AFM-Téléthon).
Read next...
New Publication: COL4A1-related autosomal recessive encephalopathy in 2 Turkish children
We are happy to have been involved with this paper presenting the neurological phenotypes of 2 Turkish brothers with a novel mutation. Through whole-exome sequencing and analysis using the RD-Connect...
New Publication: Activities of daily living in myotonic dystrophy type 1
Our new paper on activities of daily living in patients with myotonic dystrophy type 1 (DM1) is now available online at Acta Neurologica Scandinavica. We were pleased to work with...
New publication: De novo variant in SCN4A causes neonatal sodium channel myotonia with general muscle stiffness and respiratory failure
We were pleased to collaborate with colleagues in Germany on this case report describing a de novo variant in SCN4A resulting in a phenotype of general muscle stiffness, severe respiratory...
New publication: Safety and Treatment Effects of Nusinersen in Longstanding Adult 5q-SMA Type 3 – A Prospective Observational Study
We are pleased to have been involved in this new publication showing that the SMA drug nusinersen also benefits adults with 5q spinal muscular atrophy. Although the drug has received...
